Sylvia Schenker

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland.

Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson.

Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981.

International Chamber of Commerce (France) delivers solutions that address the major shifts taking place in the world economy. The non-profit company is based in Paris, France. and has subsidiaries in Cyprus, France and Hong Kong. ICC is the voice of world business championing the economy as a force for economic growth, job creation and prosperity. Making business work for everyone, everywhere, every day. The ICC arbitration rules are used all around the world to resolve disputes, administered by the ICC International Court of Arbitration®, the world’s premier arbitral institution. The rules assure parties of a neutral framework for the resolution of cross-border disputes. The CEO of the French company is Lew W. Cramer.

SIX Group AG engages in the development and operation of a central infrastructure, which ensures the flow of information and money between banks, traders, merchants, and investors. It offers products and services for securities trading, stock market transactions, financial information, and payment transactions. The company was founded in 1930 and is headquartered in Zurich, Switzerland.

Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.

Part of Klinikum der Universitaet Heidelberg, Klinik - Service - Gesellschaft am Universitatsklinikum Heidel is a company based in Heidelberg, Germany. The German company specializes in treating metabolic disorders and related diseases in endocrinology, diabetology, clinical chemistry, and metabolism. The company was founded in 2004. The CEO is Edgar Reisch.

Universitätsklinikum Heidelberg engages in the management and operation of hospitals. It offers medical services in the fields of surgery, neurology, anesthesiology, internal medicine, urology, radiology, psychiatry, orthopedics, nuclear medicine, cardiology, and oncology. The company is headquartered in Heidelberg, Germany.

Paul Sacher Stiftung operates an international research center for music. The firm also facilitates and supports scholarly research by granting access to its archive. In addition, it engages in the scholarly investigation and study of its holdings through projects and its own publications. The company was founded in 1973 and is headquartered in Basel, Switzerland.

DRK-Blutspendedienst Baden-Württemberg - Hessen GmbH is a private company based in Frankfurt, Germany. The German company's description states that it is a nationwide distributor.